Founded in 2006, DXY Insight Database（db.dxy.com） is a global pharmaceutical data intelligence and analytics platform developed by DXY. With over 20 years of continuous development in the pharmaceutical sector, we serve 3,000+ enterprises across the full industry value chain, including pharmaceutical companies, investment institutions, and pharmaceutical service providers.
Today, DXY Insight Database is trusted by leading industry players, including 92% of MNC pharma companies and 75% of China’s Top 100 pharmaceutical enterprises. As a long-term data partner to the industry, it enables organizations to quickly understand competitive landscapes, identify emerging opportunities, and make more informed decisions in new drug R&D strategy and pipeline development. db.dxy.com
ACCESS ASIA BD Forum offers bespoke collaboration packages forindustry leaders, service providers, and investors seeking visibility and engagement at one of JPM Week’s most anticipated Asia-focused biotech events.
For inquiries, please contact:
VP at YAFO, Head of ACCESS ASIA
📧wxiang@yafocapital.com
San Francisco, January 10, 2027 – As the global biopharmaceutical industry gathers in San Francisco for JPM Week, The 8th ACCESS ASIA BD Forum @ JPM 2027 will bring together Asian biotech innovators, global pharmaceutical companies, investors, and business development leaders to explore cross-border partnering opportunities.
Organized by YAFO Capital and ACCESS ASIA, the Forum connects innovative assets from China, South Korea, Japan, and across Asia with international partners, facilitating access for Asian innovation to global markets through licensing, investment, and strategic collaboration. The Forum also provides a gateway for global companies to showcase their assets and access Asian markets, creating opportunities for cross-border business development and strategic partnerships. Learn More.